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Both FSH and Sex Steroids 
Influence Bone Mass
In  our  study  (Sun  et  al.,  2006),  we 
conclude  that  FSH has  a  direct  role 
in causing bone loss in hypogonadal 
mice.  Our  study  does  not,  however, 
imply  that  estrogen  and  testoster-
one are not critical regulators of bone 
mass. To the contrary, we assert that 
sex  steroids  regulate  bone  forma-
tion  and  bone  resorption,  whereas 
FSH directly stimulates bone resorp-
tion.  Problems  in  interpretation  can 
arise  when  the  phrase  “bone  loss” 
is  used  without  defining  its  under-
lying  etiology,  that  is,  whether  it  is 
meant  to  signify  reduced  bone  for-
mation,  increased  bone  resorption, 






FSH.  However,  as  their  data  show, 
this osteopenia arises, in major part, 
from  a  dramatic  decrease  in  bone 
formation  even  in  sexually  immature 
9-week-old  mice.  Although  Sims  et 




production  and  bone  resorption  in 
mature 4-month-old hpg mice (M.Z., 
unpublished data). In our Cell paper, 
we  report  a  similar  phenotype  in 





the  absence  of  FSH  signaling  pre-
vents  the  increase  in  bone  resorp-
tion  otherwise  seen  in  hypogonadal 
states, such as after ovariectomy.
We concur with Dr. Seibel and col-
leagues  that  abrogation  of  FSH  sig-
naling  will  not  protect  against  bone 
loss  caused  by  a  defect  in  the  rate 
of  bone  formation.  In  our  paper,  we 1080  Cell 127, December 15, 2006 ©2006show that FSHRs are not expressed 
by  the mature osteoblasts  that  form 
bone  and  that  FSH  does  not  affect 
the rate of bone formation. (It remains 






cells  that  resorb  bone.  Both murine 
and  human  osteoclasts  express 
FSHRs, and FSH stimulates produc-
tion of osteoclasts, bone  resorption, 
and  the  release  of  tumor  necrosis 
factor α, which expands the number 









higher  testosterone  levels  than wild-
type  littermates  (Danilovich  et  al., 
2000; Abel et al., 2003). It is unlikely, 
however,  that  the elevated testoster-
one  noted  in  female  mice  lacking 
either FSHR or FSHβ (1.4 and 1.6 nM, 







Oz  et  al.,  2000).  In  the  presence  of 
high FSH levels in these mice, there is 
increased  osteoclastic  bone  resorp-
tion and profound bone loss (Miyaura 
et  al.,  2001).  Thus,  FSH  increases 
bone  resorption  despite  high  testo-
sterone  levels.  In  fact,  the  elevated 
levels of testosterone in female mice 
lacking either FSHβ or FSHR are  far 
below  typical  levels  in  males  (?20 
nM). Furthermore, it is even less likely  Elsevier Inc.that the skeletal conservation in mice 
lacking either FSHβ or FSHR  results 
from  aromatization  of  testosterone 
to  estrogen.  The  expression  of  the 
aromatase gene and/or serum estro-
gen  levels  are  negligible  in  either  of 
the  hypogonadal  mouse  genotypes. 
Thus, we can only conclude that the 
skeletons of mice lacking either FSHβ 
or  FSHR  are  conserved  because  of 




national  units  per  liter  (IU/l)  have 
significantly  greater  bone  loss  than 
women  with  FSH  levels  less  than 
40  IU/l  (Devleta  et  al.,  2004).  Fur-
thermore,  only  in  the  former  group 






that  changes  in  serum  FSH  rather 
than changes in serum estrogen cor-
relate strongly with changes  in bone 
mass  during  late  peri-menopause. 
Likewise,  increases  in  bone  mass 
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